Radiation-induced changes in gene expression in rectal cancer specimens

Clin Transl Oncol. 2024 Jun;26(6):1419-1428. doi: 10.1007/s12094-023-03361-9. Epub 2024 Jan 19.

Abstract

Purpose: The standard-of-care for locally advanced rectal cancer is radiotherapy-based neoadjuvant therapy followed by surgical resection. This article reviews the evidence of molecular changes at the transcriptome level induced through radiotherapy in rectal cancer.

Methods: The PubMed search "(radiation OR radiotherapy) cancer (transcriptome OR "gene expression") rectal" was used. The studies taken forward utilised gene-expression data on both pre-treatment and post-treatment rectal adenocarcinoma biospecimens from patients treated with RT-based neoadjuvant strategies.

Results: Twelve publications met the review criteria. There was variation in approaches in terms of design, patient population, cohort size, timing of the post-radiotherapy sampling and method of measuring gene expression. Most of the post-treatment biospecimen retrievals were at resection. The literature indicates a broad upregulation of immune activity through radiotherapy using gene-expression data.

Conclusion: Future studies would benefit from standardised prospective approaches to sampling to enable the inclusion of timepoints relevant to the tumour and immune response.

Keywords: Cancer; Radiotherapy; Rectal; Serial-sampling; Transcriptomics.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / genetics
  • Adenocarcinoma / pathology
  • Adenocarcinoma / radiotherapy
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic / radiation effects
  • Humans
  • Neoadjuvant Therapy
  • Rectal Neoplasms* / genetics
  • Rectal Neoplasms* / pathology
  • Rectal Neoplasms* / radiotherapy
  • Transcriptome